glp-1 macular degeneration Receptor Agonists Linked to Lower AMD Risk in Obese, Nondiabetic Patients GLP-1 Medications and Your Vision
Description
Danuglipron, developed by Pfizer, showed 813% placebo-adjusted weight loss in Phase IIb studies, though high discontinuation rates highlight ongoing challenges with GI tolerability and formulation [87, 88]
Procedures such as gastric bypass or sleeve gastrectomy typically result in 25-30% total body weight loss and often lead to diabetes remission
Medications like Ozempic and Mounjaro work effectively to increase insulin sensitivity and production, and can be an excellent tool for those with PCOS
But Rybelsus is a pill rather than an injection
